Systematic review · 2019

A systematic review of cannabidiol dosing in clinical populations.

Millar SA, Stone NL, Bellman ZD, Yates AS, England TJ, O'Sullivan SE.

Study design
Systematic review
Population / model
Human
Published
2019-07-19
Journal
British journal of clinical pharmacology

From the author abstract

“A total of 1038 articles were retrieved, of which 35 studies met inclusion criteria covering 13 medical contexts. Twenty-three studies reported a …”

A short attributed excerpt. Read the full abstract and original paper for methods, results and limitations.

Figures from the paper

Figure 1 Flow chart of study retrieval and selectionMillar SA, Stone NL, Bellman ZD, Yates AS, England TJ, O'Sullivan SE. British journal of clinical pharmacology (2019). Original figure · CC BY · Resized for display.
Figure 2 Risk of bias summary of the randomised controlled trials included in the systematic review. Green indicates low‐risk bias, red indicates high‐risk bias, and yellow indicates intermediate or unclear riskMillar SA, Stone NL, Bellman ZD, Yates AS, England TJ, O'Sullivan SE. British journal of clinical pharmacology (2019). Original figure · CC BY · Resized for display.
Citation and indexing details

PMID 31222854 · PMC6710502

Publication types: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review

Topic tags: Epilepsy; Pain; Anxiety & stress

Metadata checked 2026-11-04. Study design and model tags follow indexing and explicit abstract terms. Citation counts are not evidence of benefit. An available full text does not by itself permit image reuse.